These types of medications have been around for decades but their popularity is growing with the growing obesity epidemic
is losing trial volume to Australia and China, and a pharmacy benefits executive weighs in on why short-term cost thinking is complicating GLP-1 coverage decisions
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Unlike 503B outsourcing facilities, 503A pharmacies must maintain state licensure and follow strict compounding protocols that ensure purity, potency, and sterility
A significant up-regulation (factor of 2 0.5, p = 0.001, Table 3) of glnA1 gene transcription was observed within 0.5 hrs exposure to nitrogen starvation and continued to increase significantly thereafter (Table 3)
Following the recommended slow dose titration protocol and implementing dietary modifications substantially reduces the incidence and severity of gastrointestinal side effects